KR102526219B1 - Fmdv 재조합 백신 및 이의 용도 - Google Patents

Fmdv 재조합 백신 및 이의 용도 Download PDF

Info

Publication number
KR102526219B1
KR102526219B1 KR1020177010941A KR20177010941A KR102526219B1 KR 102526219 B1 KR102526219 B1 KR 102526219B1 KR 1020177010941 A KR1020177010941 A KR 1020177010941A KR 20177010941 A KR20177010941 A KR 20177010941A KR 102526219 B1 KR102526219 B1 KR 102526219B1
Authority
KR
South Korea
Prior art keywords
ala
thr
leu
val
gly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020177010941A
Other languages
English (en)
Korean (ko)
Other versions
KR20170058430A (ko
Inventor
장-크리스토쁘 오도네
자히아 한나스-제바라
테쇼메 메뱃션
위-웨이 치앙
저스틴 와이드너
프레드리끄 레이나르
Original Assignee
뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 filed Critical 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드
Publication of KR20170058430A publication Critical patent/KR20170058430A/ko
Application granted granted Critical
Publication of KR102526219B1 publication Critical patent/KR102526219B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/125Picornaviridae, e.g. calicivirus
    • A61K39/135Foot- and mouth-disease virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5258Virus-like particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/545Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55577Saponins; Quil A; QS21; ISCOMS
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10041Use of virus, viral particle or viral elements as a vector
    • C12N2710/10043Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/14011Baculoviridae
    • C12N2710/14041Use of virus, viral particle or viral elements as a vector
    • C12N2710/14043Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vectore
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32111Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32123Virus like particles [VLP]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32111Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020177010941A 2014-09-23 2015-09-23 Fmdv 재조합 백신 및 이의 용도 Active KR102526219B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462054073P 2014-09-23 2014-09-23
US62/054,073 2014-09-23
PCT/US2015/051755 WO2016049209A1 (en) 2014-09-23 2015-09-23 Fmdv recombinant vaccines and uses thereof

Publications (2)

Publication Number Publication Date
KR20170058430A KR20170058430A (ko) 2017-05-26
KR102526219B1 true KR102526219B1 (ko) 2023-04-26

Family

ID=54256845

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020177010941A Active KR102526219B1 (ko) 2014-09-23 2015-09-23 Fmdv 재조합 백신 및 이의 용도

Country Status (16)

Country Link
US (1) US10010605B2 (enExample)
EP (1) EP3197486A1 (enExample)
JP (1) JP6931327B2 (enExample)
KR (1) KR102526219B1 (enExample)
CN (1) CN107073100B (enExample)
AP (1) AP2017009834A0 (enExample)
AR (1) AR102006A1 (enExample)
AU (2) AU2015320673B2 (enExample)
CA (1) CA2962225A1 (enExample)
JO (1) JO3600B1 (enExample)
MA (1) MA40151B2 (enExample)
MX (1) MX388708B (enExample)
RU (1) RU2745373C2 (enExample)
TW (1) TWI733653B (enExample)
WO (1) WO2016049209A1 (enExample)
ZA (1) ZA201701851B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240087552A (ko) 2022-11-23 2024-06-19 주식회사 옵티팜 구제역 바이러스 유사 입자 또는 나노입자 생산을 위한 재조합 발현 벡터 및 이를 이용한 백신 조성물
RU2853342C1 (ru) * 2025-07-11 2025-12-23 Федеральное государственное бюджетное учреждение "Федеральный центр охраны здоровья животных" (ФГБУ "ВНИИЗЖ") Штамм "SAT-2/EGY/Alx-12" вируса ящура Aphtae epizooticae рода Aphthovirus вида Foot-and-mouth disease virus генотипа SAT-2/VII/Alx-12 для изготовления биопрепаратов для диагностики и специфической профилактики ящура

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10391163B2 (en) 2015-09-10 2019-08-27 Academia Sinica Bird flu vaccine combination comprising virus-like particles and novel adjuvants
CN108367067B (zh) 2015-11-23 2022-05-03 勃林格殷格翰动物保健美国公司 Fmdv和e2的融合蛋白质及其用途
TWI760322B (zh) 2016-01-29 2022-04-11 美商百靈佳殷格翰動物保健美國有限公司 重組腺病毒載體裝載之fmdv疫苗及其用途
US10172933B2 (en) 2016-10-31 2019-01-08 The United States Of America, As Represented By The Secretary Of Agriculture Mosaic vaccines for serotype a foot-and-mouth disease virus
CA3068052A1 (en) * 2017-07-12 2019-01-17 Boheringer Ingelheim Animal Health Usa Inc. Senecavirus a immunogenic compositions and methods thereof
CN108103034B (zh) * 2017-12-15 2022-06-24 云南农业大学动物医学院 同时表达A型、O型和Asia-1型口蹄疫病毒VP1基因重组腺病毒、构建方法及应用
CN108530522B (zh) * 2018-03-14 2021-09-17 中华人民共和国汕头海关 一种重组的OmpK多表位多肽、构建方法及其应用
CN110467654B (zh) * 2018-05-11 2022-08-09 普莱柯生物工程股份有限公司 口蹄疫病毒样颗粒抗原、其制备的疫苗组合物及其制备方法和应用
CN111233984B (zh) * 2018-11-29 2022-08-12 普莱柯生物工程股份有限公司 一种o型口蹄疫病毒样颗粒抗原、及其疫苗组合物、制备方法和应用
WO2020147015A1 (zh) * 2019-01-15 2020-07-23 普莱柯生物工程股份有限公司 口蹄疫病毒样颗粒抗原、及其疫苗组合物、制备方法和应用
CN114423779B (zh) * 2019-06-28 2024-07-02 株式会社准绳生命科学 口蹄疫病毒疫苗组合物
AR123873A1 (es) * 2020-10-22 2023-01-18 Intervet Int Bv Vector de expresión de baculovirus
AU2021363613A1 (en) * 2020-10-22 2023-05-11 Intervet International B.V. Baculovirus expression vector
US12453767B2 (en) 2021-08-18 2025-10-28 The United States Of America, As Represented By The Secretary Of Agriculture Development of mosaic vaccines against foot and mouth disease virus serotype O
WO2023020737A1 (en) * 2021-08-20 2023-02-23 Intervet International B.V. Fmdv virus-like particle with stabilizing mutation
EP4387663A1 (en) * 2021-08-20 2024-06-26 Intervet International B.V. Method of producing a foot and mouth disease virus virus-like particle
IL310905A (en) * 2021-08-20 2024-04-01 Intervet Int Bv A method for producing a virus-like particle for foot-and-mouth disease virus
EP4387665A1 (en) * 2021-08-20 2024-06-26 The Pirbright Institute Fmdv virus-like particle with double stabilizing mutation
KR102513632B1 (ko) * 2021-11-30 2023-03-28 주식회사 왓슨알앤디 구제역 바이러스 유사 입자를 생산하기 위한 백신 플랫폼
US12036318B2 (en) * 2022-02-16 2024-07-16 Chemical & Schutz High Performance Lubricants, S.A. De C.V. Self-emulsionable mineral oil as a vehicle in vaccines for poultry
JP2025538585A (ja) * 2022-11-23 2025-11-28 オプティファーム カンパニー リミテッド 口蹄疫ウィルス様粒子またはナノ粒子生産のための組換え発現ベクターおよびこれを用いたワクチン組成物
CN117210501B (zh) * 2023-09-13 2024-06-07 中国农业科学院兰州兽医研究所 口蹄疫病毒2b蛋白免疫抑制位点突变的重组口蹄疫病毒株的构建
CN117304277B (zh) * 2023-09-26 2024-03-08 中国农业科学院兰州兽医研究所 一种o型口蹄疫病毒vp4蛋白t细胞表位多肽及其应用
US20250134984A1 (en) * 2023-10-26 2025-05-01 The United States Of America, As Represented By The Secretary Of Agriculture Development of mosaic vaccines against foot and mouth disease virus serotype asia

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040001864A1 (en) * 2000-06-29 2004-01-01 King Andrew Maurice Quatermain Vaccine against foot-and-mouth disease

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA915593B (en) 1990-07-24 1993-03-31 Novagene Inc Herpesvirus-based viral vector which expresses a foot and mounth disease virus epitope on the surface of virus-infected cells and on the surface of virus particles,and vaccine against foot and mounth disease containing the same
PL1773387T3 (pl) * 2004-06-25 2013-10-31 Merial Inc Rekombinanty wirusa ospy ptasiej wyrażające geny wirusa pryszczycy
BRPI0618441B8 (pt) 2005-11-10 2021-07-27 Genvec Inc vetor adenoviral
JP5309159B2 (ja) * 2008-01-09 2013-10-09 コングク ユニバーシティ インダストリアル コーオペレーション コーポレーション バキュロウイルスを利用したワクチン
CN101270155B (zh) * 2008-05-06 2011-04-27 中国农业科学院兰州兽医研究所 通过耐酸性改造在昆虫中组装口蹄疫病毒空衣壳的方法
GB0810710D0 (en) * 2008-06-11 2008-07-16 Animal Health Inst Vaccine
NZ702145A (en) * 2010-03-12 2016-03-31 Merial Inc Bluetongue virus recombinant vaccines and uses thereof
WO2012158613A1 (en) * 2011-05-13 2012-11-22 Novartis Ag Pre-fusion rsv f antigens
GB201111183D0 (en) * 2011-06-30 2011-08-17 Animal Health Inst Peptide
US20150183835A1 (en) * 2012-06-18 2015-07-02 Novartis Ag Stabilized gp120
US9738689B2 (en) * 2013-03-13 2017-08-22 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Prefusion RSV F proteins and their use

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040001864A1 (en) * 2000-06-29 2004-01-01 King Andrew Maurice Quatermain Vaccine against foot-and-mouth disease

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Antiviral Research. 2012. Vol. 96, pp.288-295(2012.10.06.) 1부.*

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240087552A (ko) 2022-11-23 2024-06-19 주식회사 옵티팜 구제역 바이러스 유사 입자 또는 나노입자 생산을 위한 재조합 발현 벡터 및 이를 이용한 백신 조성물
RU2853342C1 (ru) * 2025-07-11 2025-12-23 Федеральное государственное бюджетное учреждение "Федеральный центр охраны здоровья животных" (ФГБУ "ВНИИЗЖ") Штамм "SAT-2/EGY/Alx-12" вируса ящура Aphtae epizooticae рода Aphthovirus вида Foot-and-mouth disease virus генотипа SAT-2/VII/Alx-12 для изготовления биопрепаратов для диагностики и специфической профилактики ящура

Also Published As

Publication number Publication date
BR112017005833A8 (pt) 2023-02-14
CA2962225A1 (en) 2016-03-31
AP2017009834A0 (en) 2017-03-31
AU2019210537A1 (en) 2019-08-15
CN107073100A (zh) 2017-08-18
BR112017005833A2 (pt) 2018-02-27
JP2017530124A (ja) 2017-10-12
TWI733653B (zh) 2021-07-21
US20160220659A1 (en) 2016-08-04
RU2017113571A3 (enExample) 2019-04-22
WO2016049209A1 (en) 2016-03-31
MA40151A1 (fr) 2018-01-31
JP6931327B2 (ja) 2021-09-01
EP3197486A1 (en) 2017-08-02
KR20170058430A (ko) 2017-05-26
JO3600B1 (ar) 2020-07-05
AR102006A1 (es) 2017-01-25
AU2015320673B2 (en) 2019-05-02
RU2017113571A (ru) 2018-10-26
CN107073100B (zh) 2021-02-26
TW201625297A (zh) 2016-07-16
AU2015320673A1 (en) 2017-05-11
MX388708B (es) 2025-03-20
MX2017003712A (es) 2017-06-28
MA40151B2 (fr) 2022-12-30
ZA201701851B (en) 2018-05-30
US10010605B2 (en) 2018-07-03
RU2745373C2 (ru) 2021-03-24

Similar Documents

Publication Publication Date Title
KR102526219B1 (ko) Fmdv 재조합 백신 및 이의 용도
RU2725495C9 (ru) Вакцины против fmdv на основе рекомбинантного аденовирусного вектора и их применение
JP6818748B2 (ja) イヌパルボウイルス(cpv)ウイルス様粒子(vlp)ワクチン及びその使用
JP6797206B2 (ja) Fmdv及びe2融合タンパク質並びにその使用
JP6347257B2 (ja) 再集合体btvおよびahsvワクチン
BR112017005833B1 (pt) Vacinas recombinantes fmdv e seus usos
HK1261142B (en) Recombinant adenovirus vectored fmdv vaccines and uses thereof
HK1261142A1 (en) Recombinant adenovirus vectored fmdv vaccines and uses thereof

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20170421

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PN2301 Change of applicant

Patent event date: 20190920

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20200821

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20220916

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20230131

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20230424

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20230424

End annual number: 3

Start annual number: 1

PG1601 Publication of registration